BIO
Bio-Rad Laboratories Inc
NYSE: BIO · HEALTHCARE · MEDICAL DEVICES
$275.15
-1.50% today
Updated 2026-04-29
Market cap
$7.43B
P/E ratio
9.88
P/S ratio
2.88x
EPS (TTM)
$27.85
Dividend yield
—
52W range
$211 – $343
Volume
0.3M
Bio-Rad Laboratories Inc (BIO) Financial statements
SEC filings — annual and quarterly data.
Profit margin
29.40%
Operating margin
8.87%
ROE
10.80%
ROA
1.67%
Debt/equity
0.21x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $1.27B | $103.26M | 55.93% | 11.47% | 8.11% |
| 2007 | $1.46B | $92.99M | 54.16% | 9.25% | 6.36% |
| 2008 | $1.76B | $89.51M | 54.55% | 10.37% | 5.07% |
| 2009 | $1.78B | $144.62M | 56.04% | 12.95% | 8.11% |
| 2010 | $1.93B | $185.49M | 56.64% | 14.74% | 9.63% |
| 2011 | $2.07B | $178.22M | 56.81% | 14.23% | 8.60% |
| 2012 | $2.07B | $169.23M | 56.11% | 12.76% | 8.18% |
| 2013 | $2.13B | $77.79M | 55.26% | 7.95% | 3.65% |
| 2014 | $2.18B | $88.84M | 54.18% | 6.90% | 4.08% |
| 2015 | $2.02B | $113.09M | 55.54% | 8.26% | 5.60% |
| 2016 | $2.07B | $28.13M | 55.03% | 2.57% | 1.36% |
| 2017 | $2.16B | $114.74M | 54.97% | 5.40% | 5.31% |
| 2018 | $2.29B | $361.00M | 53.46% | -4.74% | 15.76% |
| 2019 | $2.31B | $1.76B | 54.38% | 9.93% | 76.08% |
| 2020 | $2.55B | $3.81B | 56.48% | 16.55% | 149.83% |
| 2021 | $2.92B | $4.25B | 56.05% | 17.12% | 145.57% |
| 2022 | $2.80B | $-3.63B | 55.93% | 17.22% | -129.45% |
| 2023 | $2.67B | $-637.32M | 53.42% | 12.65% | -23.86% |
| 2024 | $2.57B | $-1.84B | 53.73% | 10.48% | -71.86% |
| 2025 | $2.58B | $759.90M | 52.01% | 10.47% | 29.42% |